<DOC>
	<DOC>NCT00719758</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of AST-120 on the PK of TRK-100STP, and to evaluate the safety and tolerability of TRK-100STP alone or in combination with AST-120</brief_summary>
	<brief_title>Drug-Drug Interaction Study of TRK-100STP</brief_title>
	<detailed_description>Non-blinded, randomized and crossover study to evaluate pharmacokinetic interaction between TRK-100STP and AST-120 in different administration condition. Nonelderly adult volunteers will receive TRK-100STP with or without AS-T120 after meal. Safety parameters will concurrently be measured.</detailed_description>
	<mesh_term>Beraprost</mesh_term>
	<mesh_term>Epoprostenol</mesh_term>
	<criteria>Provision of written informed consent Body Mass Index (BMI) of ≥17.6 to ≤26.4 kg/m2 and weight of ≥50 to ≤80 kg Clinical abnormal physical findings, including BP, pulse rate, ECG and laboratory assessments Receives any investigational medicine within 120 days before screening Recent blood donor</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>TRK-100STP,</keyword>
	<keyword>beraprost sodium,</keyword>
	<keyword>Careload LA</keyword>
	<keyword>AST-120</keyword>
	<keyword>Spherical carbon adsorbent</keyword>
	<keyword>Drug-drug interaction</keyword>
</DOC>